|
Video: What is a Stock Split?
|
|
Hancock Jaffe Laboratories is a medical device company developing tissue based solutions that are designed to be life sustaining or life improving for patients with cardiovascular disease, and peripheral arterial and venous disease. Co.'s two main products which it is developing are: the VenoValve®, a porcine based device to be surgically implanted in the deep venous system of the leg to treat a debilitating condition called chronic venous insufficiency; and the CoreoGraft®, a bovine based conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. According to our HJLI stock split history records, HJLI has had 1 split. | |
|
HJLI (HJLI) has 1 split in our HJLI stock split history database. The split for HJLI took place on November 30, 2020. This was a 1 for 25 reverse split, meaning for each 25 shares of HJLI owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split.
When a company such as HJLI conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the HJLI stock split history from start to finish, an original position size of 1000 shares would have turned into 40 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into HJLI shares, starting with a $10,000 purchase of HJLI, presented on a split-history-adjusted basis factoring in the complete HJLI stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/01/2018 |
|
End date: |
09/30/2021 |
|
Start price/share: |
$124.50 |
|
End price/share: |
$10.38 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-91.66% |
|
Average Annual Total Return: |
-52.53% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$833.88 |
|
Years: |
3.33 |
|
|
|
Date |
Ratio |
11/30/2020 | 1 for 25 |
|
|